NCT02123355

Brief Summary

The incidence of postoperative cognitive dysfunction (POCD) is high and POCD affect the life quality and the prognosis of patients. Geriatrics is the independent risk factor of POCD, and POCD is also correlated with many other factors such as type of surgery, the duration of anesthesia and the anesthesia drugs used et al. So, the prevention and treatment of POCD in geriatrics is important. Dexmedetomidine is found to have the effect of neuro-protection, but it is controversy whether Dexmedetomidine has the effect of neuro-protection in geriatrics, especially the prolonged surgery. The purpose of this study is to explore the effect of Dexmedetomidine to the cognitive function at prolonged surgery in geriatrics in geriatrics.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Aug 2014

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 20, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 25, 2014

Completed
3 months until next milestone

Study Start

First participant enrolled

August 1, 2014

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
Last Updated

April 25, 2014

Status Verified

April 1, 2014

Enrollment Period

Same day

First QC Date

April 20, 2014

Last Update Submit

April 24, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in cognitive function at 7 days

    1. Modified Newman scale to assess the cognitive function, including five tests. 2. The quiet environment, enough daylight, no disturb is needed when the modified Newman scale is done. All the five tests are finished within 30 min. 3. all the score of each test of all the patients assessed before the surgery is calculated, then get the standard variation, the score of each subject of each test is compared with the standard deviation, if one or more stand deviation decrease, then the cognitive function is considered as deterioration . 4. When 2 or more of the tests is considered as deterioration, then the patients is diagnosed as Post Operation Cognitive Dysfunction (POCD).

    Baseline, the 7th day after the surgery

Secondary Outcomes (10)

  • Brain injury assessment

    From entering the operating room to 48 hours after the surgery

  • Inflammatory responsive assessment

    From entering the operating room to 48 hours after the surgery

  • Heart rate

    From the induction of anesthesia to the right moment of extubation, up to 1 day.

  • Depth of anesthesia

    From the induction of anesthesia to the right moment of extubation, up to 1 day.

  • Recovery of anesthesia

    From the induction of anesthesia to the right moment of extubation, up to 1 day.

  • +5 more secondary outcomes

Study Arms (2)

Dexmedetomidine

EXPERIMENTAL

Dexmedetomidine is given at 0.5μg/kg/h by continuous infusion and is stopped to given 30 minutes before the surgery is over.

Drug: Induction of anesthesiaProcedure: IntubationDrug: Sevoflurane, remifentanil ,vecuroniumDrug: Dexmedetomidine

Normal saline

SHAM COMPARATOR

Normal saline is given at 0.5μg/kg/h by continuous infusion and is stopped to given 30 minutes before the surgery is over.

Drug: Induction of anesthesiaProcedure: IntubationDrug: Sevoflurane, remifentanil ,vecuroniumDrug: Placebo

Interventions

Midazolam 0.05 mg/kg、Propofol 1.0 mg/kg、Sufentanyl 3μg/kg、Victracurium 0.1 mg/kg sequential intravenous injection

DexmedetomidineNormal saline
IntubationPROCEDURE

After muscle relaxed and loss of eyelash reflex of the patients, intubation is done,then mechanical ventilation is performed, and maintain the PETCO2于35\~40 mmHg,pulse oxygen saturation is more than 95%.

DexmedetomidineNormal saline

Sevoflurane(1%-2%)is inspirated, and remifentanil 0.1-0.5μg/kg//min is continuously pumped,vecuronium 0.03 mg/kg is injected intermittently.

DexmedetomidineNormal saline

Dexmedetomidine is given at 0.5μg/kg/h by continuous infusion and is stopped to given 30 minutes before the surgery is over.

Dexmedetomidine

Normal saline is given at 0.5μg/kg/h by continuous infusion and is stopped to given 30 minutes before the surgery is over.

Normal saline

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Written informed consent
  • Scheduled for elective abdominal surgery
  • Age≥65 yrs
  • Weight is within the range of ±20% of standard weight \[standard weight=Height(cm)-80)×70﹪ for male and(Height(cm)-70)×60﹪\] for female
  • American society of anesthesia classification I\~III
  • Expected time of surgery is more than 4 hours -

You may not qualify if:

  • Systolic blood pressure≥180 mm Hg or \<90 mm Hg,diastolic blood pressure≥110 mm Hg or \< 60 mm Hg;
  • Serious cardiac,liver,kidney,lung, endocrine disease or sepsis.
  • Allergy to trial drug or other contraindication;
  • Difficult airway occurred before,or difficult airway possibly occurred and difficult to extubation
  • History of mental illness and cerebral vascular disease
  • History of unstable angina or myocardial infarction
  • Education level\<7 yrs
  • Factors existed that affect cognition assessment such as language, visual sense,auditory sense disorders.
  • Abuse of narcotic analgesia or suspected;
  • Neuromuscular diseases;
  • Mentally unstable or has a mental illness;
  • Pregnant or breast-feeding women;
  • Attended other trial past 30 days; -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Brain Injuries

Interventions

IntubationSevofluraneDexmedetomidine

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

TherapeuticsInvestigative TechniquesMethyl EthersEthersOrganic ChemicalsHydrocarbons, FluorinatedHydrocarbons, HalogenatedHydrocarbonsImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiologist

Study Record Dates

First Submitted

April 20, 2014

First Posted

April 25, 2014

Study Start

August 1, 2014

Primary Completion

August 1, 2014

Study Completion

August 1, 2014

Last Updated

April 25, 2014

Record last verified: 2014-04